April 16-18, 2024
Javits Center, NYC

2021 INTERPHEX On-Demand

By popular demand, INTERPHEX Live is back with curated panels with industry experts. The sessions are exclusively virtual and on-demand only, making it convenient for all customers to engage in high-quality, expert knowledge during and after the show.

INTERPHEX Live 2021: BioPhorum Plug and Play for Modular Automation

The BioPhorum Plug and Play Standard was conceived and developed through an industry-wide collaboration to enable the rapid deployment of modular equipment in biopharmaceutical facilities. The standard, co-developed by equipment providers, automation suppliers, and end-users, provides a common structure for defining an equipment’s automation capability.

INTERPHEX Live 2021: Creating a Sustainable Public Health Supply Chain

Speakers: Ed Kelley, PhD, Chief Health Officer, ApiJect Rob Roy, PE, IPS-Integrated Project Services Paul Fisher, IPS-Integrated Project Services Jim Fries, CEO, RX-360

INTERPHEX Live 2021: Ongoing Advancements in Cell and Gene Therapy 2021

Speakers: Kathryn Worrilow, PhD, Founder and CEO, LifeAire Systems Audrey Greenberg, Co-Founder and Chief Business Officer, Center for Breakthrough Medicines at Discovery Labs Dana Hammill, MS, MBA, Co-Founder and Chief Operating Officer, DeCart Therapeutics Graham Tulloch, PhD, Senior Director, Strategic Science, Johnson & Johnson

INTERPHEX Live 2021: The Continued Evolution of Biosimilars-Current Challenges

Speakers: Michiel E. Ultee, Ph.D, Principal, Ulteemit BioConsulting Hillel Cohen, Ph.D, Executive Director of Scientific Affairs, Sandoz Rick Morris, Ph.D, SVP, Technology, Pall Biotech

INTERPHEX Live 2021: Computer and System Integrity Enablers for Cell & Gene Therapy

Speaker: Aaron Weinstein, Senior Director, Validation Services, IPS

INTERPHEX Live 2021: Managing FDA Audits an Updated Approach

Speakers: Dina Maines Joe McGinnis

INTERPHEX Live 2021: Pros and Cons of Global Fill Finish

Responding to the COVID-19 pandemic, governments and public health agencies worldwide are developing quality vaccine programs, including local fill-finish capacity, to support global immunization. Yet even before COVID, countries were already facing increased vaccine demand due to population growth. The panel will discuss key challenges and opportunities as governments and pharmaceutical manufacturers seek to establish fill-finish facilities around the world to enable access to greater and more diversified vaccine manufacturing while improving preparedness to respond to future pandemics.
Factors include: Technical Readiness Right Size Capacity Technology Transfer Compliance Quality Speakers: Ed Kelley, PhD, Chief Health Officer, ApiJect Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals Jason Collins, AIA, Director of Process Architecture, IPS